Trial Profile
Gemcitabine with versus without tegafur/uracil in patients with resected pancreatic cancer
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 05 Nov 2010
Price :
$35
*
At a glance
- Drugs Gemcitabine (Primary) ; Tegafur/uracil (Primary)
- Indications Pancreatic cancer
- Focus Therapeutic Use
- 05 Nov 2010 New trial record.